Jiangsu Recbio Technology Co (FRA:G93) Total Assets: €213.63 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:G93 Jiangsu Recbio Technology Co Ltd FRA:G93
24 GF Score
Price €0.53
! 6 Warning Signs
View Full Analysis

What is Jiangsu Recbio Technology Co Total Assets?

Jiangsu Recbio Technology Co FRA:G93 24 Total Assets is €213.63 Mil as of Dec. 2025. GuruFocus rates FRA:G93 with a GF Score™ of 24/100. The stock has 6 warning signs investors should review.

Jiangsu Recbio Technology Co's Total Assets for the quarter that ended in Dec. 2025 was €213.63 Mil.

During the past 12 months, Jiangsu Recbio Technology Co's average Total Assets Growth Rate was -2.20% per year. During the past 3 years, the average Total Assets Growth Rate was 12.30% per year. During the past 5 years, the average Total Assets Growth Rate was 27.10% per year.

During the past 7 years, Jiangsu Recbio Technology Co's highest 3-Year average Total Assets Growth Rate was 93.00%. The lowest was 12.30%. And the median was 35.75%.

Total Assets is connected with ROA %. Jiangsu Recbio Technology Co's annualized ROA % for the quarter that ended in Dec. 2025 was -32.71%. Total Assets is also linked to Revenue through Asset Turnover. Jiangsu Recbio Technology Co's Asset Turnover for the quarter that ended in Dec. 2025 was 0.00.

Jiangsu Recbio Technology Co  (FRA:G93) Total Assets Explanation

Total Assets is connected with ROA %.

Jiangsu Recbio Technology Co's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=-65.412/( (186.273+213.625)/ 2 )
=-65.412/199.949
=-32.71 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Jiangsu Recbio Technology Co's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=0.222/( (186.273+213.625)/ 2 )
=0.222/199.949
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Jiangsu Recbio Technology Co Total Assets Related Terms

Jiangsu Recbio Technology Co Total Assets Historical Data

* Premium members only.

The historical data trend for Jiangsu Recbio Technology Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangsu Recbio Technology Co Total Assets Chart

Jiangsu Recbio Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial 266.67 312.73 280.78 254.50 213.63

Jiangsu Recbio Technology Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 263.63 254.50 186.27 213.63 204.48
FRA:G93
24GF Score
Jiangsu Recbio Technology Co Ltd FRA:G93
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jiangsu Recbio Technology Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Jiangsu Recbio Technology Co's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=85.584+128.041
=213.63

Jiangsu Recbio Technology Co's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=85.584+128.041
=213.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of €213.63 Mil mean?
Jiangsu Recbio Technology Co (FRA:G93) has a Total Assets of €213.63 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Jiangsu Recbio Technology Co and its competitors.
Is Jiangsu Recbio Technology Co's Total Assets too high?
Jiangsu Recbio Technology Co's current Total Assets is €213.63 Mil. Overall, Jiangsu Recbio Technology Co has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Recbio Technology Co's Total Assets compare to VRTX and REGN?
Jiangsu Recbio Technology Co's Total Assets of €213.63 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Jiangsu Recbio Technology Co and its competitors. Jiangsu Recbio Technology Co's current Total Assets is €213.63 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Recbio Technology Co stock overvalued right now?
Jiangsu Recbio Technology Co (FRA:G93) has a current Total Assets of €213.63 Mil. The current Total Assets is €213.63 Mil. Jiangsu Recbio Technology Co's overall GF Score™ is 24/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Jiangsu Recbio Technology Co (FRA:G93), the current Total Assets is €213.63 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jiangsu Recbio Technology Co Business Description

Other Exchanges 02179:Hong Kong
Address No. 888 Yaocheng Avenue, Medical High-tech District, Jiangsu Province, Taizhou, CHN
Jiangsu Recbio Technology Co Ltd is a vaccine company focused on the research, development, and commercialization of vaccines, with a high-value vaccine portfolio driven by in-house technologies. It has built three vaccine technology platforms: novel adjuvants, protein engineering, and immune evaluation. The company's portfolio currently consists of various vaccines, covering diseases such as cervical cancer, herpes zoster, and respiratory syncytial virus. It has two core strategic products, namely REC610, a novel adjuvanted recombinant shingles vaccine, which is currently in the stage of marketing application in China, and REC603, a recombinant HPV 9-valent vaccine under phase three clinical trial.
24GF Score

Get the complete analysis for FRA:G93

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.53
Price